+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer



Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer



Oncology Reports 12(3): 621-629



Hereditary non-polyposis colorectal cancer (HNPCC) represents 1-3% of all colorectal cancers. HNPCC is caused by a constitutional defect in a mismatch repair (MMR) gene, most commonly affecting the genes MLH1, MSH2 and MSH6. The MMR defect results in an increased cancer risk, with the greatest lifetime risk for colorectal cancer and other cancers associated to HNPCC. The HNPCC-associated tumor phenotype is generally characterized by microsatellite instability (MSI) and immunohistochemical loss of expression of the affected MMR protein. The aim of this study was to determine the sensitivity of IHC for MLH1, MSH2 and MSH6, and MSI analysis in tumors from known MMR gene mutation carriers. Fifty-eight paired normal and tumor samples from HNPCC families enrolled in our high-risk colorectal cancer registry were studied for the presence of germline mutations in MLH1, MSH2 and MSH6 by DGGE and direct sequencing. MSI analysis and immunostaining for MLH1, MSH2 and MSH6 were evaluated. Of the 28 patients with a real pathogenic mutation, loss of immunohistochemical expression for at least 1 of these MMR proteins was found, and all except 1 have MSI-H. Sensitivity by MSI analysis was 96%. IHC analysis had a sensitivity of 100% in detecting MMR deficiency in carriers of a pathogenic MMR mutation, and can be used to predict which gene is expected to harbor the mutation for MLH1, MSH2 and MSH6. This study suggests that both analyses are useful for selecting high-risk patients because most MLH1, MSH2 and MSH6 gene carriers will be detected by this 2-step approach. This practical method should have immediate application in the clinical work of patients with inherited colorectal cancer syndromes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012180612

Download citation: RISBibTeXText

PMID: 15289847

DOI: 10.3892/or.12.3.621


Related references

Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation. Journal of Medical Genetics 39(11): 833-837, 2002

Immunohistochemistry for deficiency of mismatch repair proteins MLH1, MSH2 and MSH6 identifies colorectal carcinomas with high-frequency microsatellite instability. Laboratory Investigation 82(1): 135A, 2002

MLH1 and MSH2 mutation identification from unselected patients with colorectal cancer is facilitated by the combined analysis of microsatellite instability and immunohistochemistry. American Journal of Human Genetics 67(4 Suppl. 2): 89, 2000

Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families. Human Mutation 24(4): 351, 2004

MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by genomic rearrangements in hereditary non-polyposis colorectal cancer. American Journal of Human Genetics 69(4 Suppl.): 192, 2001

MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 39(3): 250-258, 2001

Is immunohistochemistry for MLH1 and MSH2 proteins a useful method for detection of microsatellite instability in sporadic colorectal cancer?. Korean Journal of Gastroenterology 42(5): 369-376, 2003

Concordance of immunohistochemistry among HNPCC heterodimers MLH1 and PMS2, and MSH2 and MSH6 in microsatellite unstable colorectal and endometrial carcinomas. Modern Pathology 16(1): 128A-129A, 2003

Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer. Cancer Genetics and Cytogenetics 155(2): 149-151, 2004

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. Journal of Clinical Oncology 19(20): 4074-4080, 2001

Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Research 62(12): 3485-3492, 2002

Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. Journal of Gastrointestinal Surgery 2(1): 67-71, 1998

Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study. Open Access Macedonian Journal of Medical Sciences 5(1): 9, 2017

Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. Journal of Molecular Diagnostics 10(4): 301-307, 2008

Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability. British Journal of Cancer 95(12): 1678-1682, 2006